REJEUNESSE SHAPE

$35.00

Minimum order $400
Free shipping $600

Description

Rejeunesse Shape – Hyaluronic Acid Dermal Filler for Deep Contouring and Volumization

Composition: HA 24 mg/mL, Lidocaine 0.3% | Volume: 1.1 mL | Duration: 12–18 months | Pack: 1 syringe + 2 × 26G needles | Storage: 2–25°C | Shelf life: 24 months


What Is Rejeunesse Shape?

Rejeunesse Shape is a cross-linked hyaluronic acid dermal filler that Newmedic Co., Ltd in South Korea developed specifically for deep facial contouring and structural volumization. It delivers 24 mg/mL of highly purified, non-animal-derived HA in a sterile, pyrogen-free, viscoelastic gel — with 0.3% lidocaine included to minimize discomfort during treatment.

Unlike lighter fillers that target surface lines, Rejeunesse Shape reaches the deep dermis and subcutaneous layers, where structural volume loss typically occurs. As a result, its monophasic gel structure creates a uniform density that integrates smoothly into surrounding tissue without clumping or migrating. This makes it a reliable choice for practitioners who need predictable, natural-looking outcomes.

What Can Rejeunesse Shape Be Used For?

Rejeunesse Shape suits patients with significant volume loss or deep structural concerns — particularly those over 50. Common clinical applications include:

  • Very Deep Lines
  • Laugh Lines
  • Nasolabial Folds
  • Lip Contouring
  • Nose Augmentation
  • Breast Augmentation
  • Cheek/Chin/Forehead Augmentation

Because the filler targets the deep dermis-to-subcutaneous level, it works best for structural corrections rather than superficial line treatment. In addition, practitioners often pair it with finer-gauge fillers — such as Rejeunesse Fine or Rejeunesse Deep — when they need to address multiple concerns in a single session.

Key Features

  • HCCL Technology (High Concentration Cross-Linking): A patented cross-linking method that optimizes gel viscoelasticity and slows enzymatic breakdown. This structural stability may contribute to the product’s reported duration of 12–18 months.
  • UPHEC Purification Process: An advanced manufacturing process designed to minimize endotoxin levels to below 1.2 EU/mL, with no detectable BDDE residues — a meaningful safety distinction in a category where residual cross-linking agents are a known concern.
  • Non-animal HA Source: The biofermentation-derived hyaluronic acid eliminates the need for pre-treatment allergy testing and, furthermore, reduces the risk of immunogenic reactions that animal-sourced materials can trigger.
  • Monophasic Gel Structure: HA molecules of consistent size produce a uniform, stable gel that injects smoothly and integrates naturally into surrounding tissue.
  • Lidocaine 0.3%: A clinically established local anesthetic included directly in the formulation. This typically reduces procedural discomfort significantly compared to unformulated fillers.
  • CE Marked and Internationally Certified: Manufactured under ISO 13485 and cGMP standards, with regulatory approval in over 20 countries.

Benefits of Using Rejeunesse Shape

  • Pain-Free Experience: Infused with lidocaine, it ensures minimal discomfort during the injection process.
  • Non-Carcinogenic: Utilizes the safest form of hyaluronic acid, free from harmful chemicals, ensuring a risk-free experience.
  • Long-Lasting Results: The cross-linking technology ensures durability, with visible effects lasting from 12 to 18 months.
  • Immediate Results: The filler works instantly, improving skin texture, volume, and hydration upon application.

What to Expect: Results and Recovery

Patients typically notice results immediately after injection. However, mild swelling and redness at the site may temporarily affect the final appearance, so the settled outcome usually becomes clear within 2–3 days. In most cases, swelling fully resolves within one week.

Because Rejeunesse Shape targets deep tissue layers, practitioners commonly rely on techniques such as retrograde tunneling or the dual-plane approach to ensure even distribution and a natural-looking lift. Moreover, since the product is for single use only, practitioners must discard it following each procedure.

Product Specifications

SpecificationDetail
HA Concentration24 mg/mL
Lidocaine0.3%
Volume1.1 mL
Needle2 × 26G
Cross-linking AgentBDDE (no detectable residue)
Endotoxins< 1.2 EU/mL
Storage2–25°C, away from direct sunlight
Shelf Life24 months from manufacture
OriginSouth Korea (Newmedic Co., Ltd. / FHL)
CertificationsCE, ISO 13485, cGMP, Korean FDA

Frequently Asked Questions

What is Rejeunesse Shape used for?

Rejeunesse Shape targets deep wrinkle correction, facial contouring, and volumization — including cheek, chin, and jawline augmentation, nasolabial fold treatment, and non-surgical nose reshaping.

How long does Rejeunesse Shape last?

Results typically persist for 12–18 months, depending on the patient’s metabolism, the volume injected, injection technique, and the area treated.

Is Rejeunesse Shape FDA approved?

Rejeunesse products have passed an on-site FDA inspection and hold CE certification with regulatory approval in over 20 countries. Prospective buyers should verify current approval status in their specific jurisdiction.

Is Rejeunesse Shape safe?

When administered by a qualified practitioner, the formulation is designed to minimize risk through its UPHEC purification process, non-animal HA source, and absence of detectable BDDE residues. All procedures carry some inherent risk, and a thorough patient consultation is essential.

Can Rejeunesse Shape be used with a Hyaluron Pen?

No. Because of its higher viscosity and deep injection depth, Rejeunesse Shape is not compatible with a Hyaluron Pen.


Disclaimer: This product is intended for use by trained, licensed medical and aesthetics professionals only. Self-injection is not appropriate and carries significant risk of aesthetic and health complications. KBeautyPharm is not liable for any harm from self-injection.

Common post-procedure effects may include temporary redness, bruising, or mild swelling at the injection site. Contraindications include known hypersensitivity to hyaluronic acid, autoimmune conditions, pregnancy or breastfeeding, active infection at the treatment site, and use in patients under 18 years of age.

Patients taking anticoagulant or anti-inflammatory medications are generally advised to pause these before treatment to reduce bruising risk. Avoiding direct sun exposure and intense exercise for one week post-procedure may support better outcomes. 

Use the product at a time. Re-use is strictly prohibited.